Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study to Evaluate the Efficacy and Safety of DNK333

Project: Research

Project Details

StatusFinished
Effective start/end date06/15/06 → 11/25/07

Funding

  • Novartis Pharmaceuticals Corporation: $15,464.18